| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |